BioSpace News Archive

Genetown

INVOcell Enables Same-Sex Couple to Both Physically Participate in the Pregnancy and Birth of Their Child

INVO Bioscience, Inc. today announced a successful pregnancy where both partners of a same-sex couple were able to carry the baby in separate phases of the pregnancy – from the fertilization of the egg and development of the embryo to the birth of the child.

October 31, 2018
·
5 min read
Business

Electromed, Inc. Schedules Release of First Quarter Fiscal 2019 Financial Results and Conference Call

Management will host a conference call on Wednesday, November 14, 2018 at 9:00 a.m. Eastern Time to discuss the results.

October 31, 2018
·
1 min read
Business

LabShares Newton Launches Near Capacity and Announces Expansion Plans

First Life Sciences Co-Working Space Launches in Newton To Meet Growing Demand for Affordable Lab and Office Space

October 31, 2018
·
2 min read
Business

Ferring Announces Retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer

Michel Pettigrew, President of the Executive Board and Chief Operating Officer, will retire from his operational activities, effective December 31, 2018

October 31, 2018
·
2 min read
Drug Development

Galderma, Nestlé Skin Health’s Medical Solutions Business, Announces Positive Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis

Galderma, Nestlé Skin Health’s medical solutions business, today announced positive results from a Phase 2b dose-ranging study of nemolizumab in adult patients with moderate-to-severe atopic dermatitis (AD), a serious, chronic form of eczema.

October 31, 2018
·
2 min read
Business

ExoCoBio Named One of Top 4 Most Richly Funded Exosome Startups by Bioinformant

ExoCoBio raised KRW 30 billion in series B funding in September 2018 and raised KRW 12.5 billion in Series A round in 2017

October 31, 2018
·
2 min read
Business

LivaNova Reports Third Quarter 2018 Results

LivaNova PLC today reported results for the quarter ended September 30, 2018.

October 31, 2018
·
30 min read
Business

Paragon Genomics Partners Its Ultra-High Multiplexed Target Enrichment Technology With SOPHiA GENETICS For Comprehensive Genomic Solutions

Universal SOPHiA AI Platform Now Includes Paragon Genomics’ Accurate and Sensitive CleanPlex® NGS Target Enrichment Technology for Its Rapidly-Growing Global Community of Cancer Centers

October 31, 2018
·
5 min read
Drug Development

Medicenna Provides Positive Interim Update From Phase 2b Trial of MDNA55 in Recurrent Glioblastoma

Medicenna Therapeutics Corp. today announced promising interim efficacy and safety results from patients treated at low doses in the on-going Phase 2b clinical trial of MDNA55.

October 31, 2018
·
6 min read
Business

Aerpio Pharmaceuticals to Announce Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, November 7, 2018

Aerpio Pharmaceuticals, Inc. today announced that its third quarter 2018 financial results will be released before the market opens on Wednesday, November 7, 2018.

October 31, 2018
·
2 min read